ABSTRACT
INTRODUCTION
Approximately 6.6% of all breast cancers are diagnosed before age 40 years, 2.4% are diagnosed before age 35 years, and 1% are diagnosed before age 30 years. 1 Although breast cancer in young women is an uncommon condition, these cancers are considered particularly aggressive and are associated with poor prognosis. [2] [3] [4] However, because benign breast lesions are much more common than malignant tumours in young women, especially for those in their twenties, doctors may not take young women seriously when they express concerns about breast cancer. 5 Doctors usually recommend follow-up for these patients; this may lead to delay in the diagnosis of breast cancer. In addition, because screening mammography is not recommended for young women, most breast cancers are diagnosed by detection of a palpable mass. These and other factors contribute to younger women having larger and more advanced tumours at the time of diagnosis, compared with older women. 6, 7 Several studies have reported the imaging features of breast cancer in young women with different age cutoffs of 35 or 40 years [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ; however, the imaging features of breast cancer in women aged of ≤30 years have not been fully characterised. Therefore, the purpose of the present study was to identify and describe the imaging, clinicopathological, and biological characteristics of breast cancer in women aged ≤30 years, and to correlate imaging features with clinical and molecular prognostic factors of invasive breast cancer in this age-group.
METHODS

Patient Selection
This retrospective study was approved by the institutional review board of UNC-CH (University of North CarolinaChapel Hill) with a waiver of informed consent. Data of female patients aged ≤30 years who presented to the UNC-CH Breast Clinic from 2 January 2004 until 31 December 2012 and who also underwent breast imaging, a core needle biopsy, or surgical excision of a breast lesion that resulted in the diagnosis of breast cancer were extracted from hospital records. We reviewed the clinical data including age at time of diagnosis, symptoms, breast cancer gene mutations (BRCA 1/2), and family history of breast cancer in any first-or second-degree relatives.
Image Analysis
For women aged ≤30 years, ultrasonography was the initial imaging modality for evaluation of a breast lesion at our institution. General Electric, US) were performed by breast imaging radiologists with the knowledge of the clinical findings. MRI was performed using a 1.5-T system (Magnetom Avanto; Siemens, US) with a Sentinelle 7-channel breast coil (Invivo, US).
Mammograms, ultrasonograms, and MRI scans were reviewed by a breast imaging radiologist (JHL) with 10 years of experience. The radiologist was unblinded to other information. All images were analysed according to the 5th edition of the American College of Radiology Breast Imaging Reporting and Data System (ACR BI-RADS) lexicon with final assessment 19 and all analyses were presented per lesion. In case of multifocal or multicentric disease, only the main tumour, not each single lesion, was analysed to avoid data clustering.
Histopathological Analysis
Histologically reviewed data included tumour size, histological type, grade, lymph node (LN) metastasis, existence or absence of multiple or bilateral tumours, and immunohistochemical analysis to evaluate the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor type 2 (HER2). The histological type of all tumour specimens was defined according to the World Health Organization's classification system 20 and the histological grade was defined according to the Elston-Ellis method. 21 In immunohistochemical analysis, ER and PR positivity was defined as nuclear staining in more than 1% of invasive tumour cells and the intensity of HER2 staining was scored as 0, 1+, 2+ or 3+. Tumours with a score of 3+ were classified as HER2 positive; tumours with a score of 0 or 1+ were classified as negative. Tumours with a HER2 staining intensity score of 2+ underwent further fluorescence in situ hybridization analysis to confirm the HER2 status.
Statistical Analyses
Statistical analyses were performed using SPSS (Windows version 20.0; IBM Corp, Armonk [NY], US). We used Fisher's exact test for correlations between imaging features and clinical and molecular prognostic factors; p < 0.05 was considered statistically significant.
RESULTS
Clinical Data
Of 48 consecutive patients, we excluded one patient who had metastatic rhabdomyosarcoma to the breast; 47 patients were finally included in this study. The patients were aged 17 to 30 years (mean age 26.8 years). Two patients (4.3%) were aged ≤20 years, five (10.6%) were aged 21 to 25 years, and 40 (85.1%) were aged 26 to 30 years. Forty-six (97.9%) of the 47 patients were symptomatic with a palpable mass at the time of diagnosis. One patient (2.1%) had no breast symptoms and was referred to the breast clinic in the process to evaluate the cause of thrombocytopenia. Seven patients (14.9%) had a family history of breast cancer. Of 43 cases in this study where BRCA mutations were known, 10 (23.3%) were positive. Table 1 presents the imaging features. Tumour sizes ranged from 7 to 120 mm (mean, 31 mm). Mammograms were available for 42 patients; of them, 34 (81.0%) had heterogeneously or extremely dense breast composition. The overall sensitivity of mammography was 95.2% (40 / 42). The most common lesion type was a mass with or without calcifications. Other findings included asymmetries in three patients (7.1%), focal asymmetries in two (4.8%), architectural distortion in one (2.4%), and skin and trabecular thickening in one (2.4%). The predominant mammographic features of the mass-type lesions were an irregular shape (77.8%) and indistinct margins (33.3%).
Imaging Features
Ultrasonography was performed in 45 patients. Mass was the most frequent (97.8%) lesion type seen. In addition, these masses had suspicious features for malignancy, which were assessed as category 4 (82.2%) or 5 (17.8%) in all cases. Only one lesion (2.2%) was a non-mass lesion with the appearance of a hypoechoic region with internal echogenic foci, and it was assessed as a category 4 lesion. After final assessment based on both mammography and ultrasonography, 29.7% of lesions originally assessed as category 4 based on ultrasonography only were reassessed as category 5 ( Figure 1) . Of the 17 patients who underwent MRI, 16 (94.1%) of the lesions presented as a mass on MRI. Only one (5.9%) lesion presented as non-mass enhancement. Of the MRI masses, 87.5% had an irregular shape. The most common mass margin features were irregular or spiculated (87.5%) and the most common enhancement pattern was heterogeneous (62.5%). Table 2 summarises the histopathological and molecular characteristics of the patients included in the present study. Of the 47 patients, 40 underwent surgery and 25 of these patients had neoadjuvant chemotherapy before surgery. Of the 47 patients, 41 (87.2%) had invasive ductal carcinoma, three (6.4%) of whom had ductal carcinoma in situ. Tumour sizes ranged from 0.1 to 56 mm (mean 19 mm), and tumours <20 mm accounted for 25 (62.5 %) of the 40 patients who underwent surgery. Invasive tumours were predominately high nuclear grade (grade 3; 69.0%), and 25.6% of the tumours were triplenegative (TN) breast cancer.
Histopathological Data
Statistical Analysis
There was a significant positive correlation between the mammographic mass margin features and expression of BRCA mutation (p = 0.0217). In patients with a BRCA mutation, 83.3% (5 / 6) of the tumours had indistinct margin on mammogram. The ultrasonogram mass margin features, echogenicity, and associated posterior features were significantly correlated with the expression of ER (p = 0.0176, 0.0135, 0.0467, respectively) and PR (p = 0.0117, 0.0235, 0.0305, respectively). Eighty-six percent (6 / 7) of the masses with a spiculated margin on ultrasonography were both ER-and PR-positive and 75% (3 / 4) of the complex cystic and solid masses were TN subtypes. A BI-RADS assessment based on both mammography and ultrasonography was significantly correlated with the presence of LN metastasis (p = 0.0076). Of the cases without axillary LN metastasis, 80% (16 / 20) were assessed as category 4; of the cases with axillary LN metastasis, 66.7% (12 / 18) were assessed as category 5 (Figure 2 ).
In the correlation of clinical characteristics with histopathological and prognostic factors, the expression of BRCA mutation correlated significantly with the histological grade (p = 0.0243). All 10 tumours in patients with BRCA mutation were high grade 3, and 84.6% (11 / 13) of low-grade (grade 1 and 2) tumours were in patients with no BRCA mutation. 13, 15 or even ≤50 23 years). The selected age range of subjects was decided with consideration of the age commonly applied in clinical practice in deciding first-line imaging. 15 To the best of our knowledge, there has been only one study on characteristic imaging features and the correlation with imaging features and clinical and molecular prognostic factors of breast cancer in women aged ≤30 years, and this was conducted in only Asian women. 
(a) (b)
Patients enrolled in breast cancer screening programmes were excluded from analysis; these patients are likely to have dense breast tissue on mammography, making it more difficult to differentiate between tumours and normal breast tissue. 8, 9 Our results showed that most patients had palpable symptoms (97.9%) and invasive carcinoma (89.4%), likely owing to the non-screened population and the poorer prognosis of breast cancers in young women. 9 Family history of breast cancer is more common in women aged ≤40 years than in postmenopausal women. 8, 22, 25 Although family history of breast cancer in young breast cancer patients is common, Loman et al 25 reported that only 9% of patients had BRCA 1/2 mutations. In the present study of women aged ≤30 years, only 14.9% of patients had a family history of breast cancer, but 23.3% had BRCA 1/2 mutations. This may be attributed to the differences in the ethnicity and the age cut-off of enrolled patients compared with the study by Loman et al.
25
Older studies on imaging features of breast cancer in young women have used analogue techniques or had incomplete radiological data without following the guidelines of ACR BI-RADS. These older studies reached conclusions on the frequent pseudo-benign presentation of cancers in young women, and found that detection rates for breast cancer by mammography were low. [11] [12] [13] More recent studies have reported sensitivities of mammography, ranging from 76% to 89% in the diagnosis of breast cancer in young women. 9, 14, 15, 24 The higher sensitivity in recent studies may be due to advances in breast imaging technologies, including digital mammography and computer-aided diagnosis, and the introduction of ACR BI-RADS guidelines for image analysis. In the present study, sensitivity of mammography was 95.2%, despite the high percentage of dense breast composition (81.0%). In addition to technological improvements, these favourable results may be because most cases (78.6%) in this study had suspicious calcifications that were easily detected by mammography and because the tumours tended to be large (mean size, 31 mm).
Although mammography is the gold standard for the diagnosis of breast cancer, many studies have reported that ultrasonography is an appropriate initial imaging test for symptomatic young women. [14] [15] [16] [17] [18] In our study, the sensitivity of ultrasonography was 100%. There are several reasons for this result. First, there have been significant technical improvements in ultrasonography equipment, including high-frequency linear probes with high spatial resolution. Also, software advancements such as compound image, harmonic image, elastography and colour Doppler image are helpful for characterising breast lesions. Second, radiologists trained in breast imaging perform real-time ultrasonography. This may lead to more accurate and valid diagnoses than using static ultrasonogram images collected by a technologist. Third, the use of the precise descriptive lexicon and assessment categories in accordance with ACR BI-RADS may improve the characterisation of a mass. Finally, the radiologist reported the final assessment of the ultrasonogram with knowledge of the clinical information and the mammogram result; this was considered a positive factor influencing to the diagnosis.
The most common ultrasonography features of the masses-irregular shape, indistinct margins, and hypoechoicity or heterogeneity echotexture-recorded in the present study (90.9%, 34.1%, and 88.6%, respectively) are consistent with those reported in a study by An et al (75.6%, 57.8% and 77.8%, respectively). 24 The histopathological and biological results of the present study-including the incidence of high grade 3 (69.0%), ER-negative lesions (38.6%), PR-negative lesions (43.2%), HER2 overexpression (25.6%), and LN metastasis (47.4%)-are similar to those of previous studies of young women aged ≤40 years, 8, 14, 22 ,26 but higher than those of postmenopausal women.
22,23,27-29
These results demonstrate that breast cancers in women aged ≤40 years have a more aggressive profile and a poorer prognosis than those in postmenopausal women.
The correlation of imaging features with molecular prognostic factors of invasive breast tumours has recently been described in all age-groups and in younger agegroups: significantly more spiculated lesions are found in ER/PR-positive groups 8, 30, 31 ; and tumours with HER2 overexpression are significantly correlated with the presence of calcifications on mammograms. 14, 24, 31 Our study also demonstrated a significant correlation between the ultrasonography mass features and expression of ER and PR. Most spiculated masses on ultrasonography were both ER-and PR-positive (85.7%). There were no ER-and PR-negative lesions with spiculated margins. Most complex cystic and solid masses (75%, 3 / 4) were TN breast cancer, reflecting tumoural necrosis in these high-grade tumours. 31 The higher assessment category (category 5) was significantly correlated with LN metastasis (p = 0.008), likely because the radiologists reported the comprehensive imaging results and could upgrade the categories of the lesions from 4 to 5 when the patients had LN enlargement with suspicious features in their axilla in addition to the suspicious masses in their breasts (Figure 2 ).
Previous studies have reported that the TN subtype is often associated with BRCA mutations and that 10.6% to 14% of TN breast cancers are BRCA 1/2 mutations.
32-34
Our study showed that 27.3% (3 / 11) of the TN breast cancer was in patients with a BRCA mutation. The expression of BRCA mutation was significantly correlated with the histological grade (p = 0.0243). In addition, in all patients with BRCA mutation, the tumours were grade 3. In contrast, in patients with no BRCA mutation, the majority (11 / 13) of the tumours were of low histological grade 1 and 2. This is consistent with the results of the study by Schrading and Kuhl, 35 who found that 70% of tumours in women of all ages with BRCA mutations were high grade.
There are several limitations of this study. First, this was a retrospective study at a single institution with a small sample size. The number of cases could limit statistical outcomes. Second, the reviewing radiologist was unblinded to the clinical and histological information and this might be influencing the image analysis. The results may have differed if the radiologist was blinded to the results and if there was more than one reviewing radiologist. Third, a number of clinicopathological data were missing or unavailable for review and this could have also affected the results. A large prospective multicentre study is recommended to decrease these limitations and to further evaluate breast cancer in these patients.
CONCLUSIONS
Breast cancer in young women aged ≤30 years frequently presents as a palpable mass with suspicious imaging features that are assigned BI-RADS category 4 or 5. Some imaging and clinical features are significantly associated with prognostic factors of breast cancer. Radiologists should be aware of the characteristic features in women aged ≤30 years to avoid delaying the diagnosis of breast cancer in this patient population.
